Furthermore, numerous studies have confirmed that TRAIL-related signaling pathways are involved in the pathology of a variety of central nervous system disorders, including Alzheimer’s disease (Wu et al., 2015), multiple sclerosis (Lopez-Gomez et al., 2016), and ischemic stroke (Cui et al., 2010). Here, TNFSF10 is linked to ischemic stroke.